FR940922-2-00065 FR940922-2-00039 [Docket No. 94N&hyph;0044] Riker Laboratories, Inc., et al.; Withdrawal of Approval of 91 New Drug Applications; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration (FDA) is correcting a document that withdrew approval of 91 new drug applications (NDA's). The document was published in the Federal Register of March 2, 1994 (59 FR 9989). This document corrects the name of one of the drugs. FOR FURTHER INFORMATION CONTACT: Nancy G. Maizel, Center for Drug Evaluation and Research (HFD&hyph;53), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4320. SUPPLEMENTARY INFORMATION: In FR Doc. 94&hyph;4660, appearing on page 9989, in the Federal Register of Wednesday, March 2, 1994, the following correction is made: In the table on page 9991 in the entry for NDA 17&hyph;485, the drug name ``Vosol Otic Solution'' is corrected to read ``Vosol Wick Otic Solution.'' Dated: September 2, 1994. Janet Woodcock, Director, Center for Drug Evaluation and Research. [FR Doc. 94&hyph;23506 Filed 9&hyph;21&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
